Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Targeted Search
Clinical Trials Search Results
Query: "TILT[LastUpdatePostDate]SEARCH[Study]AREA[SponsorSearch]LEO Pharma"
Count: 262
Selected: 0
| NCT ID | Title |
|---|
| NCT01320774 | Efficacy, Tolerability and Handling of Daivobet® Gel in Patients With Psoriasis Vulgaris | ||
| NCT05388760 | Tralokinumab Monotherapy for Children With Moderate-to-severe Atopic Dermatitis - TRAPEDS 1 (TRAlokinumab PEDiatric Trial no. 1) | ||
| NCT03587805 | Long-term Extension Trial in Subjects With Atopic Dermatitis Who Participated in Previous Tralokinumab Trials - ECZTEND | ||
| NCT05259722 | A 24 Week Trial to Compare the Efficacy and Safety of Delgocitinib Cream 20 mg/g Twice-daily With Alitretinoin Capsules Once-daily in Adult Participants With Severe Chronic Hand Eczema | ||
| NCT05355818 | Efficacy and Safety of Delgocitinib Cream in Adolescents 12-17 Years of Age With Moderate to Severe Chronic Hand Eczema | ||
| NCT04306315 | Adjusted Brodalumab Dose Compared With Standard Brodalumab Dose in Subjects With Moderate-to-severe Plaque Psoriasis and ≥120 kg Body Weight | ||
| NCT04305327 | Efficacy and Safety of Brodalumab in Adolescents From 12 to 17 Years of Age With Moderate-to-severe Plaque Psoriasis | ||
| NCT05470114 | A Multi-omics Disease Signature Trial in Adult Patients With Moderate to Severe AD | ||
| NCT05682352 | Investigating the Safety of LEO 158968 in Healthy Volunteers | ||
| NCT03160885 | Tralokinumab Monotherapy for Moderate to Severe Atopic Dermatitis - ECZTRA 2 (ECZema TRAlokinumab Trial no. 2) | ||
| NCT03131648 | Tralokinumab Monotherapy for Moderate to Severe Atopic Dermatitis - ECZTRA 1 (ECZema TRAlokinumab Trial no. 1) | ||
| NCT05194540 | Tralokinumab Administered With Device A in Adults and Adolescents With Moderate-to-severe Atopic Dermatitis | ||
| NCT05117060 | Efficacy and Safety of LEO 152020 Tablets for the Treatment of Adults With Moderate to Severe Atopic Dermatitis | ||
| NCT05486117 | Pharmacokinetics of Delgocitinib 20 mg/g Cream in Subjects With Chronic Hand Eczema | ||
| NCT04883333 | A Single and Multiple Ascending-dose Trial of LEO 153339 in Healthy Adults | ||
| NCT04533737 | Efficacy and Safety of Brodalumab Compared With Guselkumab in the Treatment of Plaque Psoriasis After Inadequate Response to Ustekinumab | ||
| NCT04872101 | Efficacy and Safety of Delgocitinib Cream in Adults With Moderate to Severe Chronic Hand Eczema (DELTA 2) | ||
| NCT05508776 | A Trial to Evaluate the Effect of LEO 152020 on the Heart of Healthy People | ||
| NCT04949841 | Open-label Multi-site Extension Trial in Subjects Who Completed the DELTA 1 or DELTA 2 Trials | ||
| NCT05332366 | A Trial to Assess the Effect of Delgocitinib Cream 20 mg/g on the Molecular Signature, Safety, and Efficacy in Adults With Frontal Fibrosing Alopecia | ||
| NCT04871711 | Efficacy and Safety of Delgocitinib Cream in Adults With Moderate to Severe Chronic Hand Eczema | ||
| NCT04922021 | An Evaluation of LEO 138559 in Adults With Moderate to Severe Atopic Dermatitis. | ||
| NCT03562377 | Vaccine Responses in Tralokinumab-Treated Atopic Dermatitis - ECZTRA 5 (ECZema TRAlokinumab Trial No. 5) | ||
| NCT04587453 | Tralokinumab in Combination With Topical Corticosteroids in Japanese Subjects With Moderate-to-severe Atopic Dermatitis | ||
| NCT04853992 | Trial to Assess the Efficacy and Safety of LEO 152020 in Adult Patients With Cholinergic Urticaria | ||
| NCT03526861 | Tralokinumab Monotherapy for Adolescent Subjects With Moderate to Severe Atopic Dermatitis - ECZTRA 6 (ECZema TRAlokinumab Trial no. 6). | ||
| NCT05099133 | A Trial to Evaluate Pharmacokinetics, Immunogenicity, Safety, and Tolerability of LEO 138559 in Healthy Japanese Subjects | ||
| NCT01722812 | Cromoglicate in Psoriasis | ||
| NCT03673527 | Tacrolimus Blood Levels After Topical Application of Tacrolimus on Healthy Skin | ||
| NCT05050279 | A Trial to Evaluate the Effect of Delgocitinib on the Heart Rhythm of Healthy People | ||
| NCT04674826 | A Trial to Compare the Pharmacokinetics of Tralokinumab in Healthy Subjects | ||
| NCT04203836 | A Trial to Evaluate the Effect of Food on LEO 152020 | ||
| NCT03826901 | Delgocitinib Cream for the Treatment of Moderate to Severe Atopic Dermatitis During 8 Weeks in Adults, Adolescents, and Children | ||
| NCT03761537 | Tralokinumab in Combination With Topical Corticosteroids in Subjects With Severe Atopic Dermatitis - ECZTRA 7 | ||
| NCT00506519 | Recombinant Human Antithrombin (ATryn®) in the Treatment of Patients With DIC Associated With Severe Sepsis | ||
| NCT00691002 | Efficacy and Safety of Calcipotriol Plus Hydrocortisone Ointment in Psoriasis Vulgaris on the Face and Skin Folds | ||
| NCT04807751 | Clinical Trial to Evaluate UV-light-induced Allergic Skin Reactions After Application of Delgocitinib Cream | ||
| NCT02668692 | LEO 80185 Gel (Calcipotriol Hydrate Plus Betamethasone Dipropionate) in Japanese Subjects With Psoriasis | ||
| NCT01963793 | Topical Aprepitant in Prurigo Patients | ||
| NCT03725722 | Dose-ranging Trial to Evaluate Delgocitinib Cream 1, 3, 8, and 20 mg/g Compared to Delgocitinib Cream Vehicle Over an 8-week Treatment Period in Adult Subjects With Atopic Dermatitis. | ||
| NCT03231124 | Multiple Dose Study With Incremental Dosing to Evaluate the Safety, Tolerability, and Pharmacokinetics of Oral Doses of LEO 32731 in Healthy Male Japanese Subjects. | ||
| NCT03958955 | Efficacy and Safety of Delgocitinib Cream in Discoid Lupus Erythematosus. | ||
| NCT01787383 | A Simultaneous Treatment Regimen Compared to a Sequential Treatment Regimen With Ingenol Mebutate Gel 0.015% and 0.05% of Two Areas With Actinic Keratosis on Face/Scalp and Trunk/Extremities | ||
| NCT02935582 | PSOREAL - Managing PSOriasis in the REAL World | ||
| NCT01820260 | Safety and Efficacy of Ingenol Mebutate Once Daily for 2 or 3 Consecutive Days in Subjects With Actinic Keratosis | ||
| NCT03683719 | Phase 2b Dose-ranging Trial to Evaluate Delgocitinib Cream 1, 3, 8, and 20 mg/g Compared to Delgocitinib Cream Vehicle Over a 16-week Treatment Period in Adult Subjects With Chronic Hand Eczema | ||
| NCT03402828 | Body PSOriasis: Long-term Relapse CONTROL | ||
| NCT03514511 | Safety and Tolerability of LEO 138559 in Healthy Subjects and Subjects With Atopic Dermatitis | ||
| NCT03363854 | Tralokinumab in Combination With Topical Corticosteroids for Moderate to Severe Atopic Dermatitis - ECZTRA 3 | ||
| NCT03806790 | Efficacy and Safety of LEO 90100 Foam in Japanese Subjects With Psoriasis Vulgaris |
